8-K: AITX's RAD Secures Major Healthcare ROAMEO Robot Orders

Sentiment:

New Order Announcement


Artificial Intelligence Technology Solutions' subsidiary, RAD, secured a full-price order for two ROAMEO Gen 4 mobile security robots from a major non-profit hospital network.

Better than expectedSecured a full-price production order, not just a proof-of-concept, from a major healthcare network.The order is for two units, with discussions for additional deployments, indicating strong client satisfaction and potential for expansion.The client expressed interest in RAD's broader ecosystem, suggesting future cross-selling opportunities.This win validates the product's strength and accelerates market momentum.Deployment is expected quickly, by the end of the month.RAD has expanded production, indicating high demand and a robust sales pipeline.

Summary

  • Artificial Intelligence Technology Solutions, Inc. (AITX) and its subsidiary Robotic Assistance Devices, Inc. (RAD) secured a full-price order for two ROAMEO Gen 4 mobile security robots.
  • The order is from one of the largest non-profit hospital networks in the United States.
  • This represents a production contract, not a proof-of-concept, expected to deliver significant savings and performance improvements for the client.
  • The robots will be integrated into security operations at two locations, with discussions for additional deployments underway.
  • The client expressed strong interest in RAD's broader ecosystem of solutions.
  • This order follows a trend of accelerating adoption for ROAMEO across multiple industries.

Sentiment

Score: 9

Explanation: The filing announces a significant production order from a major client, validating the company's technology and business model. It highlights accelerating adoption, strong sales pipeline, and recurring revenue potential, all positive indicators for future growth and financial performance.

Positives

  • Secured a full-price production order for two ROAMEO Gen 4 mobile security robots from a major healthcare network.
  • The order is expected to generate significant savings and performance improvements for the end user.
  • The client is interested in RAD's broader ecosystem, indicating potential for future sales.
  • This win validates the strength of RAD's solutions and accelerates momentum across sectors.
  • Deployment of the first unit is expected by the end of September 2025, indicating quick implementation.
  • RAD has expanded production commitments to meet rising demand, suggesting a strong sales pipeline.
  • Each deployment generates significant recurring monthly revenue (RMR).
  • The company's operations and internal controls have been validated through a successful SOC 2 Type 2 audit.
  • RAD has a prospective sales pipeline of over 35 Fortune 500 companies.

Risks

  • The information contained in this publication does not constitute an offer to sell or solicit an offer to buy securities.
  • The Company makes no representations or warranties, expressed or implied, as to the accuracy or completeness of the information provided.
  • The Company has no obligation to provide the recipient with additional updated information.
  • No information in this publication should be interpreted as any indication whatsoever of the Company's future revenues, results of operations, or stock price.

Future Outlook

The company expects this success to stimulate additional opportunities and reinforce the value delivered to clients, channel partners, and shareholders. RAD anticipates continued growth and conversion of its sales pipeline, including over 35 Fortune 500 companies, into deployed clients generating recurring revenue streams. They also expect each Fortune 500 client to make numerous reorders over time.

Management Comments

  • "We see this deployment as a powerful catalyst for ROAMEO's continued growth. When a healthcare provider of this scale moves straight to a production order, it validates the strength of our solutions and accelerates the momentum we are building across every sector we serve. We expect this success to stimulate additional opportunities and reinforce the value we deliver to our clients, channel partners and shareholders." Steve Reinharz, CEO/CTO and founder of AITX and RAD.
  • "Most client sites will require more than one ROAMEO to maintain uninterrupted coverage. Because each unit requires scheduled recharging, most sites benefit from operating multiple robots to ensure continuous coverage. Even with just two units in service, healthcare providers can realize significant efficiencies compared to traditional manned patrols, while enhancing the consistency and reliability of their security operations." Mark Folmer, CPP, PSP, President of RAD.

Industry Context

The security and guarding services industry, valued at nearly $50 billion in the US, is undergoing a transformation with increasing demand for autonomous solutions. Healthcare networks, in particular, face complex security challenges across large campuses, making mobile security robots like ROAMEO a valuable force-multiplying solution. This order highlights a broader trend of large enterprises and public institutions adopting AI-driven autonomous patrols to reduce costs, enhance security coverage, and generate recurring revenue.

Comparison to Industry Standards

  • RAD solutions are designed to provide cost savings to businesses of between 35%-80% when compared to the industry's existing and costly manned security guarding and monitoring model.
  • ROAMEO's autonomous patrols offer significant efficiencies compared to traditional manned patrols, enhancing consistency and reliability.
  • The company's SOC 2 Type 2 audit completion reinforces its credibility with enterprise and government clients who require strict data protection and security compliance, aligning with high industry standards.

Stakeholder Impact

  • Shareholders: Positive impact due to new production orders, potential for increased revenue, RMR, and validation of the business model, which could lead to increased share price.
  • Customers (Healthcare Network): Expected to realize significant cost savings and performance improvements in security operations, enhanced safety for staff and patients, and more consistent security coverage.
  • Employees (RAD/AITX): Increased demand and expanded production commitments may lead to job stability or growth opportunities.
  • Security Personnel (at client site): ROAMEO acts as a force-multiplying solution, easing the burden on human security personnel and allowing them to focus on more strategic tasks.

Next Steps

  • Deployment of the first ROAMEO unit by the end of September 2025.
  • Integration of ROAMEO robots into the healthcare network's security operations at two locations.
  • Discussions for additional ROAMEO deployments with the major healthcare network.
  • Continued advancement of multiple large-scale opportunities through the sales pipeline.
  • Conversion of existing sales opportunities into deployed clients generating recurring revenue.
  • Potential reorders from Fortune 500 clients over time.

Key Dates

DateDescription
2025-09-23Date of earliest event reported and press release issuance regarding ROAMEO orders.
2025-09-30Expected deployment of the first ROAMEO unit by the end of the month.

Recommendation

strong buy

The announcement of a full-price production order from a major healthcare network for two ROAMEO units, with potential for further expansion, is a strong validation of AITX's technology and business model. This is not a pilot but a direct integration, indicating high confidence from a significant client. The expected significant cost savings for the client, coupled with RAD's ability to generate recurring monthly revenue (RMR) and its robust pipeline of Fortune 500 opportunities, suggest substantial future growth. The company's SOC 2 Type 2 audit further enhances its credibility. This news signals accelerating market adoption and strong financial prospects, making it a compelling 'strong buy' for investors.

Keywords

Artificial Intelligence Technology Solutions, AITX, Robotic Assistance Devices, RAD, ROAMEO, Mobile Security Robots, Healthcare Security, AI Security, Autonomous Patrols, Security Solutions, RMR, SOC 2 Type 2

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.